Canada Pension Plan Investment Board Buys 78,126 Shares of Humana Inc. $HUM

Key Points

• The Canada Pension Plan Investment Board increased its stake in Humana Inc. by 41.4%, holding a total of 266,979 shares valued at approximately $70.6 million.
• Humana reported Q2 earnings of $6.27 per share, slightly missing consensus estimates, but its revenue of $32.39 billion exceeded analysts' expectations.
• The company declared a quarterly dividend of $0.885 per share, with a yield of 1.2%, scheduled for payment on October 31st.

Canada Pension Plan Investment Board grew its holdings in Humana Inc. (NYSE:HUM - Free Report) by 41.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 266,979 shares of the insurance provider's stock after acquiring an additional 78,126 shares during the quarter. Canada Pension Plan Investment Board owned 0.22% of Humana worth $70,643,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares in the last quarter. Riverview Trust Co bought a new position in shares of Humana during the first quarter worth about $34,000. Garde Capital Inc. bought a new position in shares of Humana during the first quarter worth about $36,000. Zions Bancorporation National Association UT bought a new position in shares of Humana during the first quarter worth about $37,000. Finally, Whipplewood Advisors LLC grew its holdings in shares of Humana by 639.1% during the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock worth $45,000 after buying an additional 147 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Robert W. Baird decreased their price objective on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Bank of America increased their price objective on Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a report on Tuesday. Morgan Stanley decreased their price objective on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Finally, Royal Bank Of Canada increased their price target on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a research report on Thursday, August 21st. Seven research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $285.76.

Humana Stock Performance

Shares of HUM traded up $2.16 during mid-day trading on Wednesday, reaching $312.22. The company's stock had a trading volume of 1,739,414 shares, compared to its average volume of 1,706,351. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $382.72. The stock has a market cap of $37.55 billion, a P/E ratio of 23.96, a PEG ratio of 1.79 and a beta of 0.44. The business has a 50-day simple moving average of $257.24 and a two-hundred day simple moving average of $255.32. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business's revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio (DPR) is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.